MedMira Inc (MIR):企業の財務・戦略的SWOT分析

◆英語タイトル:MedMira Inc (MIR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME330FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedMira Inc (MedMira) is a developer, manufacturer and marketer of rapid diagnostics and technology platforms. The company offers products in the areas of HIV, H. pylori, multiplex, syphilis, miriad rvf toolkit, and tissue and eye banks. MedMira offers Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics. The company serves hospitals, point-of-care facilities, laboratories, governments, public health agencies, and other sectors. MedMira markets its products through a network of distributors and business development partners. The company operates through its manufacturing facilities located in Nova Scotia, Canada; and sales offices in the US. MedMira is headquartered in Halifax, Nova Scotia, Canada.

MedMira Inc Key Recent Developments

Mar 31,2021: MedMira Reports Second Quarter Results FY2021
Dec 25,2020: MedMira reports first quarter results FY2021
Nov 30,2020: MedMira reports FY2020 fourth quarter and year end financial results
Jun 29,2020: MedMira reports third quarter results FY2020
Mar 31,2020: MedMira reports second quarter results FY2020

This comprehensive SWOT profile of MedMira Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MedMira Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MedMira Inc – Key Information
MedMira Inc – Overview
MedMira Inc – Key Employees
MedMira Inc – Key Employee Biographies
MedMira Inc – Key Operational Heads
MedMira Inc – Major Products and Services
MedMira Inc – History
MedMira Inc – Company Statement
MedMira Inc – Locations And Subsidiaries
MedMira Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MedMira Inc – Business Description
MedMira Inc – Corporate Strategy
MedMira Inc – SWOT Analysis
SWOT Analysis – Overview
MedMira Inc – Strengths
MedMira Inc – Weaknesses
MedMira Inc – Opportunities
MedMira Inc – Threats
MedMira Inc – Key Competitors

Section 3 – Company Financial Performance Charts

MedMira Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MedMira Inc, Key Information
MedMira Inc, Key Ratios
MedMira Inc, Share Data
MedMira Inc, Major Products and Services
MedMira Inc, History
MedMira Inc, Key Employees
MedMira Inc, Key Employee Biographies
MedMira Inc, Key Operational Heads
MedMira Inc, Other Locations
MedMira Inc, Subsidiaries
MedMira Inc, Key Competitors
MedMira Inc, SWOT Analysis
MedMira Inc, Ratios based on current share price
MedMira Inc, Annual Ratios
MedMira Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[MedMira Inc (MIR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Buckle, Inc.:企業の戦略・SWOT・財務情報
    The Buckle, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Buckle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Astute Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Astute Medical Inc (Astute Medical) is a healthcare service provider that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in the field of identifying and validating biomarkers of acute kidney injury through …
  • XsunX Inc (XSNX):企業の財務・戦略的SWOT分析
    XsunX Inc (XSNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • ROSEN Swiss AG:企業の戦略的SWOT分析
    ROSEN Swiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • UnitedHealth Group Inc (UNH)-製薬・医療分野:企業M&A・提携分析
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • Compania Espanola de Petroleos SAU:企業の戦略的SWOT分析
    Compania Espanola de Petroleos SAU - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Centice Corporation-製薬・医療分野:企業M&A・提携分析
    Summary Centice Corporation (Centice) is a medical and electronic equipment company which designs, develops and offers advance sensors for various applications. The company’s products include BTL-200N, MFL-300N, BTL-200P, MFL-300P, and MFL-3000. It also provides illicit substances, prescription drug …
  • Samsung Medison Co Ltd:企業の戦略的SWOT分析
    Samsung Medison Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Cypress Semiconductor Corporation (CY):企業の財務・戦略的SWOT分析
    Cypress Semiconductor Corporation (CY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Merit Energy Company:石油・ガス:M&Aディール及び事業提携情報
    Summary Merit Energy Company (Merit Energy) is a financial service provider that offers oilfield investment services. The company provides direct investments in oil and gas assets. It purchases properties with a high percentage of producing reserves, implements exploitation projects to increase prod …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Kumho Petrochemical Co Ltd (011780):企業の財務・戦略的SWOT分析
    Kumho Petrochemical Co Ltd (011780) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pacific & Orient Berhad:企業の戦略・SWOT・財務分析
    Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report Summary Pacific & Orient Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • DiaMedica Therapeutics Inc (DMA):医療機器:M&Aディール及び事業提携情報
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務情報
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Catabasis Pharmaceuticals Inc (CATB):製薬・医療:M&Aディール及び事業提携情報
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Meggitt Plc (MGGT):企業の財務・戦略的SWOT分析
    Meggitt Plc (MGGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • UDG Healthcare Plc (UDG):企業の財務・戦略的SWOT分析
    UDG Healthcare Plc (UDG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Eyevensys SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Eyevensys SAS (Eyevensys) is a clinical stage biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its lead product, EYS-606, is a soluble TNFa receptor plasmid associated with the ETIS device to treat non-infectious intermediate and posterior uveitis(NIU); EYS- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆